Elutia Corporation (ELUT): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand Elutia Corp (ELUT)

Rising demand for wound-healing matrices promises Elutia Inc. further expansion, as confirmed by the P/S levels on the chart. 3.90 determines the latest valuation metric, based on tissue cleansing patents and strict FDA oversight. Business stability is bolstered by management's expertise in commercializing protective shells and transparent operations with clinics.

Price-to-Revenue Ratio: Elutia (ELUT) for 02/21/2024 - 11/13/2026

Metric breakdowns and analytics for Elutia Corp (ELUT)

- stock quotes and analyst forecast:
Price elutia.com|ELUT - Price Target Chart
- stock exchange capitalization data:
Market Value Elutia Corp|ELUT - Real Price to Acquire Entire Company
- book capitalization indicators:
Book Value per Share Elutia|ELUT - Company Book Value|Market Cap to Net Assets Ratio elutia.com|ELUT - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital Elutia Inc.|ELUT - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Elutia Corporation|ELUT - Company Total Debt|Debt to Book Capital Elutia Corp|ELUT - Company Long-Term Debt|Short-Term Debt Volume Elutia|Immediate Liquidity elutia.com
- company profitability and valuation multiples indicators:
ELUT - Company Net Income|Expected Profit Elutia Inc.|ELUT - Price to Earnings Ratio|Forward P/E Multiple Elutia Inc|ELUT - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Elutia Corp|ELUT - Operating profit EBITDA|Net earnings per share for the last four quarters Elutia|ELUT - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth elutia.com|ELUT - Net earnings per share growth this year|Expected earnings per share trend next year Elutia Inc.
- total revenue and sales volume data:
ELUT - Revenue and Sales Volume|Company Future Sales elutia.com|ELUT - Price-to-Revenue Ratio|Market Cap to Projected Revenue Elutia Corp
Summary company analytics:elutia.com
Mass-produced product of elutia.com

For Elutia Inc. (ELUT), the correlation between market value and actual sales determines the investment attractiveness of implant innovations. This metric relates total market capitalization to annual revenue, measuring the premium the market is willing to pay for patient safety. By analyzing the company's rolling P/S ratio, an investor can identify whether the asset is overbought relative to its operational achievements. Exceeding historical highs signals a risk of overvaluation, even amidst high surgeon confidence.

Competitors of Elutia Inc.

Market Cap to Sales Volume ISRG|Price-to-Revenue Ratio Danaher DHR|Market Capitalization-to-Revenue Ratio BDX|STE: Market Cap to Revenue|WST - P/S Multiple|Baxter International (BAX) - Price-to-Revenue Ratio|Market Cap to Revenue masimo.com|STVN (Stevanato Group) - P/S Multiple|Price to Sales Teleflex Inc. TFX|Price-to-Revenue Ratio Merit Medical Systems Inc (MMSI)|Nobel Biocare - Market Cap to Revenue Ratio|ICU Medical, Inc. - Market Cap to Revenue|Market Cap to Sales Volume XRAY (dentsplysirona.com)|LMAT - Price-to-Revenue Ratio|Price-to-Revenue Coefficient AtriCure Inc ATRC|STAA: P/S Multiple|Price to Sales Niagen (NAGE)|Price-to-Revenue Ratio ZimVie Inc.|Price-to-Revenue Ratio ANGO|Market Cap to Revenue CERS (Cerus)|P/S Multiple Alpha Teknova (TKNO)|Monogram Technologies Inc - Market Cap to Revenue|Market Cap to Sales Volume STSS (Sharps Technology Inc)|InfuSystem Inc - P/S Multiple|Price-to-Revenue Coefficient utahmed.com UTMD|KRMD: P/S Multiple|Nyxoah SA (NYXH) - P/S Multiple|Market Cap to Revenue MBOT|PDEX: Market Capitalization-to-Revenue Ratio|P/S Multiple ZTEK|Price-to-Revenue Coefficient milestonescientific.com|Price-to-Revenue Ratio NEXGEL NXGL|RVP: Market Cap to Revenue Ratio|Harvard Bioscience - P/S Multiple|Femasys Corporation (FEMY) - Market Cap to Revenue|MHUA (meihuamed.com) - Market Cap to Revenue|POAI - Price-to-Revenue Coefficient|CJMB (Callan JMB Inc.) - P/S Multiple|Price to Sales Atrion Corp. ATRI|Price-to-Revenue Ratio NeuroMetrix Corp (NURO)